At 17.2x earnings and 15.7x forward earnings, CLX trades like a stable defensive compounder, but the PEG of 2.1 signals the market is paying a full price for limited growth. The Altman Z-Score of 3.1 indicates no immediate balance sheet distress, yet the combination of a 0.7 current ratio and 15.00% debt/equity suggests constrained liquidity flexibility. A 27.40% ROIC is elite and implies durable competitive advantages, but the staggering -604.00% operating margin distortion clouds true profitability quality. This is not obviously mispriced—rather, it appears fairly valued to slightly expensive given muted growth expectations and mixed financial strength signals.
⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.